Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of nonmelanoma skin cancer.

Autor: Silk AW; Merkel Cell Carcinoma Center of Excellence, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA ann_silk@dfci.harvard.edu isaac.brownell@nih.gov., Barker CA; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Bhatia S; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, Washington, USA., Bollin KB; Hematology and Medical Oncology, Scripps MD Anderson Cancer Center, San Diego, California, USA., Chandra S; Hematology Oncology Division, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA., Eroglu Z; Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, USA., Gastman BR; Melanoma and High-Risk Skin Cancer Program, Cleveland Clinic Cancer Center, Cleveland, Ohio, USA., Kendra KL; Division Of Medical Oncology, The Ohio State University, Columbus, Ohio, USA., Kluger H; Yale Cancer Center, Yale University, New Haven, Connecticut, USA., Lipson EJ; Bloomberg Kimmel Institute for Cancer Immunotherapy, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, Maryland, USA., Madden K; Melanoma/Cutaneous Oncology Program, New York University Langone Perlmutter Cancer Center, New York, New York, USA., Miller DM; Department of Medicine and Department of Dermatology, Massachusetts General Cancer Center, Boston, Massachusetts, USA., Nghiem P; Division of Dermatology, Department of Medicine, University of Washington, Seattle, Washington, USA., Pavlick AC; Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, New York, USA., Puzanov I; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA., Rabinowits G; Department of Hematology/Oncology, Miami Cancer Institute/Baptist Health South Florida, Miami, Florida, USA., Ruiz ES; Mohs and Dermatologic Surgery Center, Dana-Farber/Brigham and Women's Hospital, Boston, Massachusetts, USA., Sondak VK; Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, USA., Tavss EA; Independent Contributor, New Brunswick, New Jersey, USA., Tetzlaff MT; Dermopathology Division, University of California San Francisco, San Francisco, California, USA., Brownell I; Dermatology Branch, National Institutes of Health, Bethesda, Maryland, USA ann_silk@dfci.harvard.edu isaac.brownell@nih.gov.

Publikováno v: Journal for immunotherapy of cancer [J Immunother Cancer] 2022 Jul; Vol. 10 (7).

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

High-potency sodium fluoride: a literature review.

Autor: Tavss EA; Colgate-Palmolive Company, Piscataway, New Jersey, USA., Bontá CY, Joziak MT, Fisher SW, Campbell SK

Publikováno v: Compendium of continuing education in dentistry (Jamesburg, N.J. : 1995) [Compend Contin Educ Dent] 1997; Vol. 18 (2 Spec No), pp. 31-6.

Factors affecting pH rise of suspended salivary sediment.

Autor: Tavss EA, Eigen E

Publikováno v: Caries research [Caries Res] 1986; Vol. 20 (3), pp. 244-50.